US Patent Issued to Alexion Pharmaceuticals on May 27 for "Methods of producing anti-C5 antibodies" (Connecticut Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,394, issued on May 27, was assigned to Alexion Pharmaceuticals Inc. (Boston).

"Methods of producing anti-C5 antibodies" was invented by Hunter F. Malanson (Wallingford, Conn.), Kyle A. Zingaro (Southington, Conn.), Anjil Giri (Hamden, Conn.), Justin Weaver (Manchester, Conn.), Abraham Friedman (West Hartford, Conn.), Jeffrey William Hunter (Wallingford, Conn.), Saranya Sivanandam (Norwalk, Conn.), Jeffrey Zugates (Hamden, Conn.) and Rahul Godawat (Woodbridge, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a method of producing an anti-C5 antibody (ravulizumab), wherein the method comprises: -culturing mammali...